V. Dolby

发表

Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study

N. Taub, D. Greenwood, C. Wild, 2008, BMJ : British Medical Journal.

Caffeine intake during pregnancy, late miscarriage and stillbirth

N. Taub, D. Greenwood, C. Wild, 2010, European Journal of Epidemiology.

Sources of excess steroid prescriptions and clinical adverse outcomes associated with steroid excess in patients with inflammatory bowel disease: The Leeds IBD Steroids study

C. Selinger, J. Carbonell, T. Raine, 2022, Alimentary pharmacology & therapeutics.

P147 Safety and efficacy of ustekinumab for Crohn’s disease (CD): the cross pennine experience

Rachael C. Walker, C. Stansfield, C. Selinger, 2021, Posters.

Does Nausea and Vomiting of Pregnancy Play a Role in the Association Found Between Maternal Caffeine Intake and Fetal Growth Restriction?

N. Taub, D. Greenwood, C. Wild, 2013, Maternal and Child Health Journal.

Variants in the fetal genome near FLT1 are associated with risk of preeclampsia

D. Lawlor, U. Thorsteinsdóttir, K. Stefánsson, 2017 .

Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women

D. Lawlor, D. Gudbjartsson, U. Thorsteinsdóttir, 2020, Nature Communications.

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

A. de Silvestri, C. Stansfield, C. Selinger, 2021, Alimentary pharmacology & therapeutics.

Variants in the fetal genome near FLT1 are associated with risk of preeclampsia

D. Lawlor, U. Thorsteinsdóttir, K. Stefánsson, 2017, Nature Genetics.

Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study

D. Greenwood, J. Cade, S. Boylan, 2008, BMJ : British Medical Journal.